Fortior made an IPO

BRIEF: Cloudbreak tumbles in Hong Kong trading debut

Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) opened down 6% in its Hong Kong trading debut on Wednesday, and continued to fall during the morning session to close down 30% at HK$7.04…
Fortior made an IPO

BRIEF: Cloudbreak launches $78 million Hong Kong IPO

Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) launched its Hong Kong IPO on Tuesday, aiming to sell 60.58 million shares at HK$10.10 apiece to raise about HK$610 million ($78 million). Share…
Bayzed does healthcare

BRIEF: WuXi XDC’s revenue, profit jump in 2024

WuXi XDC Cayman Inc. (2268.HK), a provider of contract services for drug companies, said on Wednesday its revenue and profit rose sharply last year on strong demand for services related…